{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:17:13Z","timestamp":1778573833864,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"am","delay-in-days":271,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["MR141044"],"award-info":[{"award-number":["MR141044"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-15-2-002"],"award-info":[{"award-number":["W81XWH-15-2-002"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.trim.2022.101696","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T23:28:45Z","timestamp":1660778925000},"page":"101696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Tacrolimus before CTLA4Ig and rapamycin promotes vascularized composite allograft survival in MGH miniature swine"],"prefix":"10.1016","volume":"75","author":[{"given":"Tarek Y.","family":"Elgendy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Waldner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wensheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deokyeol Y.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta I.","family":"Minervini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiaki","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yalcin","family":"Kulahci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kia M.","family":"Washington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay S.","family":"Gorantla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed B.","family":"Ezzelarab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario G.","family":"Solari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angus W.","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.trim.2022.101696_bb0005","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/PRS.0b013e3181c15c4c","article-title":"First U.S. near-total human face transplantation: a paradigm shift for massive complex injuries","volume":"125","author":"Siemionow","year":"2010","journal-title":"Plast. Reconstr. Surg."},{"issue":"4","key":"10.1016\/j.trim.2022.101696_bb0010","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/SCS.0000000000004615","article-title":"Face transplantation: an update for the United States trauma system","volume":"29","author":"Farber","year":"2018","journal-title":"J Craniofac Surg"},{"issue":"4","key":"10.1016\/j.trim.2022.101696_bb0015","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/SCS.0000000000004633","article-title":"Perceived esthetic outcomes of face transplantation: a survey of the general public","volume":"29","author":"Cabrera","year":"2018","journal-title":"J Craniofac Surg"},{"issue":"5","key":"10.1016\/j.trim.2022.101696_bb0020","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s10856-017-5880-0","article-title":"Outcomes after hand and upper extremity transplantation","volume":"28","author":"Shores","year":"2017","journal-title":"J. Mater. Sci. Mater. Med."},{"issue":"12","key":"10.1016\/j.trim.2022.101696_bb0025","first-page":"1762","article-title":"Long-term outcome after hand and forearm transplantation - a retrospective study, transplant international\u202f: official journal of the European Society for Organ","volume":"33","author":"Hautz","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2022.101696_bb0030","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/438078","article-title":"The need for inducing tolerance in vascularized composite allotransplantation","volume":"2012","author":"Ravindra","year":"2012","journal-title":"Clin. Dev. Immunol."},{"issue":"4","key":"10.1016\/j.trim.2022.101696_bb0035","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41423-019-0215-3","article-title":"Composite tissue allotransplantation: opportunities and challenges","volume":"16","author":"Iske","year":"2019","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.trim.2022.101696_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.544186","article-title":"Costimulation blockade in vascularized composite allotransplantation","volume":"11","author":"Giannis","year":"2020","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.trim.2022.101696_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.trre.2022.100708","article-title":"What we still don\u2019t know about vascularized composite allotransplantation (VCA) outcomes and quality of life measurements","volume":"36","author":"Bound Alberti","year":"2022","journal-title":"Transplant. Rev."},{"issue":"3","key":"10.1016\/j.trim.2022.101696_bb0050","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bjps.2007.10.048","article-title":"Immunosuppression in an emerging field of plastic reconstructive surgery: composite tissue allotransplantation","volume":"61","author":"Madani","year":"2008","journal-title":"J. Plast. Reconstr. Aesthet. Surg."},{"issue":"3","key":"10.1016\/j.trim.2022.101696_bb0055","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00006534-199103000-00001","article-title":"Relative antigenicity of components of a vascularized limb allograft","volume":"87","author":"Lee","year":"1991","journal-title":"Plast. Reconstr. Surg."},{"issue":"4","key":"10.1016\/j.trim.2022.101696_bb0060","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/micr.30408","article-title":"Relative antigenicity of components in vascularized composite allotransplants: an experimental study of microRNAs expression in rat hind limb transplantation model","volume":"39","author":"Oda","year":"2019","journal-title":"Microsurgery"},{"issue":"6","key":"10.1016\/j.trim.2022.101696_bb0065","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/MOT.0000000000000023","article-title":"Update on infections in composite tissue allotransplantation","volume":"18","author":"Avery","year":"2013","journal-title":"Curr Opin Organ Transplant"},{"issue":"8","key":"10.1016\/j.trim.2022.101696_bb0070","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1016\/j.transproceed.2014.09.004","article-title":"Impact of immunosuppressive treatment on the cardiovascular system in patients after hand transplantation","volume":"46","author":"Boratynska","year":"2014","journal-title":"Transplant. Proc."},{"issue":"5","key":"10.1016\/j.trim.2022.101696_bb0075","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0272-6386(99)70414-2","article-title":"Incidence and long-term cost of steroid-related side effects after renal transplantation","volume":"33","author":"Veenstra","year":"1999","journal-title":"Am. J. Kidney Dis."},{"issue":"6","key":"10.1016\/j.trim.2022.101696_bb0080","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/MOT.0000000000000140","article-title":"Acute rejection in vascularized composite allotransplantation","volume":"19","author":"Fischer","year":"2014","journal-title":"Curr Opin Organ Transplant"},{"issue":"1","key":"10.1016\/j.trim.2022.101696_bb0085","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1182\/blood-2006-01-0329","article-title":"Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production","volume":"108","author":"Zeiser","year":"2006","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.trim.2022.101696_bb0090","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1097\/TP.0000000000001379","article-title":"Impact of immune-modulatory drugs on regulatory T cell","volume":"100","author":"Furukawa","year":"2016","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.trim.2022.101696_bb0095","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/01.tp.0000284808.28353.2c","article-title":"Sirolimus versus cyclosporine therapy increases circulating regulatory T cells, but does not protect renal transplant patients given alemtuzumab induction from chronic allograft injury","volume":"84","author":"Ruggenenti","year":"2007","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.trim.2022.101696_bb0100","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1097\/TP.0000000000000717","article-title":"Differential effects of Calcineurin and mammalian target of rapamycin inhibitors on alloreactive Th1, Th17, and regulatory T cells","volume":"99","author":"Gallon","year":"2015","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.trim.2022.101696_bb0105","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/hep.25579","article-title":"Systemic immunoregulatory and proteogenomic effects of tacrolimus to sirolimus conversion in liver transplant recipients","volume":"57","author":"Levitsky","year":"2013","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.trim.2022.101696_bb0110","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1600-6143.2005.00749.x","article-title":"Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties","volume":"5","author":"Larsen","year":"2005","journal-title":"Am. J. Transplant."},{"issue":"11","key":"10.1016\/j.trim.2022.101696_bb0115","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1111\/ajt.12460","article-title":"Long-term belatacept exposure maintains efficacy and safety at 5 years: results from the long-term extension of the BENEFIT study","volume":"13","author":"Rostaing","year":"2013","journal-title":"Am. J. Transplant."},{"issue":"4","key":"10.1016\/j.trim.2022.101696_bb0120","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJMoa1506027","article-title":"Belatacept and long-term outcomes in kidney transplantation","volume":"374","author":"Vincenti","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.trim.2022.101696_bb0125","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1111\/ajt.13379","article-title":"Studies introducing Costimulation blockade for vascularized composite allografts in nonhuman Primates","volume":"15","author":"Freitas","year":"2015","journal-title":"Am. J. Transplant."},{"issue":"8","key":"10.1016\/j.trim.2022.101696_bb0130","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1111\/ajt.13217","article-title":"Tacrolimus to Belatacept conversion following hand transplantation: a case report","volume":"15","author":"Cendales","year":"2015","journal-title":"Am. J. Transplant."},{"issue":"9","key":"10.1016\/j.trim.2022.101696_bb0135","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1016\/j.transproceed.2011.10.010","article-title":"Biologics and donor bone marrow cells for targeted immunomodulation in vascularized composite allotransplantation: a translational trial in swine","volume":"43","author":"Wachtman","year":"2011","journal-title":"Transplant. Proc."},{"issue":"9","key":"10.1016\/j.trim.2022.101696_bb0140","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1097\/01.ASN.0000085020.78117.70","article-title":"Memory T cells: a hurdle to immunologic tolerance","volume":"14","author":"Lakkis","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.trim.2022.101696_bb0145","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1600-6143.2005.01215.x","article-title":"The challenge of inhibiting alloreactive T-cell memory","volume":"6","author":"Valujskikh","year":"2006","journal-title":"Am. J. Transplant."},{"issue":"2","key":"10.1016\/j.trim.2022.101696_bb0150","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/TP.0b013e31815e870e","article-title":"Long-term survival of limb allografts induced by pharmacologically conditioned, donor alloantigen-pulsed dendritic cells without maintenance immunosuppression","volume":"85","author":"Ikeguchi","year":"2008","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.trim.2022.101696_bb0155","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12967-017-1322-5","article-title":"Therapeutic application of T regulatory cells in composite tissue allotransplantation","volume":"15","author":"Yang","year":"2017","journal-title":"J. Transl. Med."},{"issue":"5","key":"10.1016\/j.trim.2022.101696_bb0160","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/ajt.15726","article-title":"Adipose-derived stromal cell therapy combined with a short course nonmyeloablative conditioning promotes long-term graft tolerance in vascularized composite allotransplantation","volume":"20","author":"Schweizer","year":"2020","journal-title":"Am. J. Transplant."},{"issue":"3","key":"10.1016\/j.trim.2022.101696_bb0165","first-page":"C2","article-title":"Comparative analysis of bone marrow versus blood monocyte-derived regulatory dendritic cells for evaluation in a miniature swine vascular composite allotransplantation model","volume":"17","author":"Elgendy","year":"2017","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2022.101696_bb0170","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1097\/TP.0000000000003977","article-title":"The MHC-characterized miniature swine: lessons learned from a 40-year experience in transplantation","volume":"1;106(5)","author":"Matar","year":"2022","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2022.101696_bb0175","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jss.2020.04.026","article-title":"Heterotopic transplantation of allogeneic vertical rectus abdominis Myocutaneous flaps in miniature swine","volume":"254","author":"Waldner","year":"2020","journal-title":"J. Surg. Res."},{"issue":"2","key":"10.1016\/j.trim.2022.101696_bb0180","doi-asserted-by":"crossref","first-page":"E81","DOI":"10.1111\/ctr.12086","article-title":"Standardizing skin biopsy sampling to assess rejection in vascularized composite allotransplantation","volume":"27","author":"Hautz","year":"2013","journal-title":"Clin. Transpl."},{"issue":"7","key":"10.1016\/j.trim.2022.101696_bb0185","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1111\/j.1600-6143.2008.02243.x","article-title":"The Banff 2007 working classification of skin-containing composite tissue allograft pathology","volume":"8","author":"Cendales","year":"2008","journal-title":"Am. J. Transplant."},{"issue":"4","key":"10.1016\/j.trim.2022.101696_bb0190","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0009-9120(01)00235-1","article-title":"Simultaneous simple and fast quantification of three major immunosuppressants by liquid chromatography--tandem mass-spectrometry","volume":"34","author":"Volosov","year":"2001","journal-title":"Clin. Biochem."},{"issue":"6","key":"10.1016\/j.trim.2022.101696_bb0195","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.4155\/bio.10.58","article-title":"LC-MS\/MS for immunosuppressant therapeutic drug monitoring","volume":"2","author":"Sallustio","year":"2010","journal-title":"Bioanalysis"},{"issue":"6","key":"10.1016\/j.trim.2022.101696_bb0200","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1051\/vetres:2008030","article-title":"Membrane markers of the immune cells in swine: an update","volume":"39","author":"Piriou-Guzylack","year":"2008","journal-title":"Vet. Res."},{"issue":"1","key":"10.1016\/j.trim.2022.101696_bb0205","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/MOT.0000000000000592","article-title":"Novel immunological and clinical insights in vascularized composite allotransplantation","volume":"24","author":"Kollar","year":"2019","journal-title":"Curr Opin Organ Transplant"},{"issue":"5","key":"10.1016\/j.trim.2022.101696_bb0210","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/MOT.0000000000000456","article-title":"Immunosuppression maintenance in vascularized composite allotransplantation: what is just right?","volume":"22","author":"Howsare","year":"2017","journal-title":"Curr Opin Organ Transplant"},{"issue":"11","key":"10.1016\/j.trim.2022.101696_bb0215","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1111\/ajt.14353","article-title":"Belatacept combined with transient Calcineurin inhibitor therapy prevents rejection and promotes improved long-term renal allograft function","volume":"17","author":"Adams","year":"2017","journal-title":"Am. J. Transplant."},{"issue":"5","key":"10.1016\/j.trim.2022.101696_bb0220","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/ajt.12712","article-title":"Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors","volume":"14","author":"Kirk","year":"2014","journal-title":"Am. J. Transplant."},{"issue":"12","key":"10.1016\/j.trim.2022.101696_bb0225","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1111\/ajt.14440","article-title":"Benefits and limitations of belatacept in 4 hand-transplanted patients","volume":"17","author":"Grahammer","year":"2017","journal-title":"Am. J. Transplant."},{"issue":"4","key":"10.1016\/j.trim.2022.101696_bb0230","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/MOT.0000000000000656","article-title":"The past, present, and future of costimulation blockade in organ transplantation","volume":"24","author":"Schroder","year":"2019","journal-title":"Curr Opin Organ Transplant"},{"issue":"3","key":"10.1016\/j.trim.2022.101696_bb0235","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00007890-200202150-00004","article-title":"Feasibility of immunosuppression in composite tissue allografts by systemic administration of CTLA4Ig","volume":"73","author":"Iwasaki","year":"2002","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.trim.2022.101696_bb0240","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1006\/jsre.1996.0268","article-title":"The time course of CTLAIg effect on cardiac allograft rejection","volume":"63","author":"Bolling","year":"1996","journal-title":"J. Surg. Res."},{"issue":"2","key":"10.1016\/j.trim.2022.101696_bb0245","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/01.TP.0000072019.76043.B5","article-title":"Difficulty of achieving long-term graft survival of MHC-disparate composite graft using CTLA4IG","volume":"76","author":"Ajiki","year":"2003","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.trim.2022.101696_bb0250","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1185\/03007995.2016.1157463","article-title":"Indirect treatment comparison of belatacept versus tacrolimus from a systematic review of immunosuppressive therapies for kidney transplant patients","volume":"32","author":"Muduma","year":"2016","journal-title":"Curr. Med. Res. Opin."},{"issue":"7","key":"10.1016\/j.trim.2022.101696_bb0255","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1111\/ajt.14910","article-title":"De novo belatacept in clinical vascularized composite allotransplantation","volume":"18","author":"Cendales","year":"2018","journal-title":"Am. J. Transplant."},{"issue":"2","key":"10.1016\/j.trim.2022.101696_bb0260","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1053-2498(00)00256-4","article-title":"CTLA4Ig and donor-specific transfusion prolongs cardiac allograft survival in the miniature swine","volume":"20","author":"Lee","year":"2001","journal-title":"J. Heart Lung Transplant."},{"issue":"8","key":"10.1016\/j.trim.2022.101696_bb0265","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1111\/j.1600-6143.2011.03573.x","article-title":"The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients","volume":"11","author":"Flechner","year":"2011","journal-title":"Am. J. Transplant."},{"issue":"5","key":"10.1016\/j.trim.2022.101696_bb0270","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/TP.0000000000001004","article-title":"An acute cellular rejection with detrimental outcome occurring under Belatacept-based immunosuppressive therapy: an immunological analysis","volume":"100","author":"de Graav","year":"2016","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.trim.2022.101696_bb0275","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/ajt.14217","article-title":"A tale of two pathways: renewing the promise of anti-CD40L blockade","volume":"17","author":"Thomson","year":"2017","journal-title":"Am. J. Transplant."},{"issue":"4","key":"10.1016\/j.trim.2022.101696_bb0280","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s40620-017-0411-0","article-title":"Late conversion from tacrolimus to a belatacept-based immuno-suppression regime in kidney transplant recipients improves renal function, acid-base derangement and mineral-bone metabolism","volume":"30","author":"Schulte","year":"2017","journal-title":"J. Nephrol."},{"issue":"5","key":"10.1016\/j.trim.2022.101696_bb0285","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1053\/j.ajkd.2016.09.021","article-title":"Safety and efficacy outcomes 3 years after switching to Belatacept from a Calcineurin inhibitor in kidney transplant recipients: results from a phase 2 randomized trial","volume":"69","author":"Grinyo","year":"2017","journal-title":"Am. J. Kidney Dis."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327422001708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327422001708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:05:29Z","timestamp":1778573129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327422001708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":57,"alternative-id":["S0966327422001708"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2022.101696","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tacrolimus before CTLA4Ig and rapamycin promotes vascularized composite allograft survival in MGH miniature swine","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2022.101696","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101696"}}